Live at Annual Episode 5: Pharmacy Debates - The role of ketamine in status epilepticus
Release Date:
Following their debate on approaches to early phase management of refractory status epilepticus (RSE), Salia Farrokh, PharmD is joined by Caroline Der Nigoghossian, Neurocritical Care PharmD, Renad Abu-Sawwa, PharmD, and Gabe Fontaine, PharmD to explore the benefits and harms/risks of early ketamine administration in refractory status epilepticus, as well as the emerging literature for the use of ketamine in pediatric neurocritical care.
Live at Annual Episode 5: Pharmacy Debates - The role of ketamine in status epilepticus